Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.

Archives of gynecology and obstetrics - 3 Apr 2026

Han Ying, Han Ruxue, Jiang Xingran, Qu Hong, Lu Jun, Li Hua

Abstract excerpt

OBJECTIVES: To evaluate the prognostic utility of the FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in endometrial cancer. METHODS: A total of 172 patients between 2015 and 2020 diagnosed with endometrial cancer in our center were included in this study. Molecular classification subtypes were classified using DNA sequencing and immunohistochemistry. The clinical characteristics and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to DNA Polymerase II

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Immunohistochemistry

Share to Neoplasm Staging

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 41931130
DOI: 10.1007/s00404-026-08370-x
PMCID: PMC13048923

Genes

POLE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FIGO 2023 staging system with/without molecular classification vs. FIGO 2009 in 172 endometrial cancer patients.PMID 41931130Read ↗

FIGO 2023 Staging and Molecular Classification of 172 patients with Endometrial CancerSemantic proximity Read ↗

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort.Semantic proximity Read ↗

Molecular classification-driven stage migration and prognostic risk stratification in endometrial cancers: FIGO 2023 vs FIGO 2009.Semantic proximity Read ↗

Association of Molecular Classification with FIGO Stage and Survival Outcomes in Endometrial Cancer.Semantic proximity Read ↗

Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohortSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancerSemantic proximity Read ↗

Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer.Semantic proximity Read ↗

Analysis of Differences in the Classification of Endometrial Cancer Patients in PolandSemantic proximity Read ↗

Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practiceSemantic proximity Read ↗

New clinicopathological concept of endometrial carcinoma with integration of histological features and molecular profiles.Semantic proximity Read ↗

Impact of molecular classification on recurrence risk in endometrial cancer patients with lymph node metastasis: multicenter retrospective study.Semantic proximity Read ↗

Application of novel algorithm on a retrospective series to implement the molecular classification for endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.